Advanced search
Publication Cover
Leukemia & Lymphoma Volume 63, 2022 - Issue 13
Submit an article Journal homepage
158
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor

A nomogram using cytogenetics, TP53, and NPM1 mutational status can predict responses to induction chemotherapy in AML

Konstantinos Lontosa UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-0216-3818View further author information
ORCID Icon,
Anastasia Tsagiannia UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USAView further author information
,
Mounzer Aghaa UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USAView further author information
,
Anastasios Raptisa UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USAView further author information
,
Jing-Zhou Houa UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USAView further author information
,
Rafic Faraha UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USAView further author information
,
Robert L. Rednera UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USAView further author information
,
Annie Ima UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USAView further author information
,
Kathleen A. Dorritiea UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USAView further author information
,
Alison Sehgala UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USAORCID Iconhttps://orcid.org/0000-0003-3954-7401View further author information
ORCID Icon,
James Rossettia UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USAView further author information
,
Nidhi Aggarwalb Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USAView further author information
,
Melissa Saulc Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USAView further author information
,
William Goodingd Biostatistics Facility, UPMC Hillman Cancer Center, Pittsburgh, PA, USAView further author information
&
Michael Boyiadzisa UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USAView further author information
 show all
Pages 3257-3260 | Received 26 May 2022, Accepted 23 Aug 2022, Published online: 08 Sep 2022

References

  • Papaemmanuil E, Gerstung M, Bullinger L, et al. Genomic classification and prognosis in acute myeloid leukemia. N Engl J Med. 2016;374(23):2209–2221.
  • Patel JP, Gonen M, Figueroa ME, et al. Prognostic relevance of integrated genetic profiling in acute myeloid leukemia. N Engl J Med. 2012;366(12):1079–1089.
  • Kantarjian H, Kadia T, DiNardo C, et al. Acute myeloid leukemia: current progress and future directions. Blood Cancer J. 2021;11(2):41.
  • Estey E, Karp JE, Emadi A, et al. Recent drug approvals for newly diagnosed acute myeloid leukemia: gifts or a Trojan horse? Leukemia. 2020;34(3):671–681.
  • Perl AE. The role of targeted therapy in the management of patients with AML. Blood Adv. 2017;1(24):2281–2294.
  • Michaelis LC. Cytotoxic therapy in acute myeloid leukemia: not quite dead yet. Hematology Am Soc Hematol Educ Program. 2018;2018(1):51–62.
  • Short NJ, Rytting ME, Cortes JE. Acute myeloid leukaemia. Lancet. 2018;392(10147):593–606.
  • Roloff GW, Griffiths EA. When to obtain genomic data in acute myeloid leukemia (AML) and which mutations matter. Blood Adv. 2018;2(21):3070–3080.
  • Yount RJ, Vries JK, Councill CD. The medical archival system: an information-retrieval system based on distributed parallel processing. Inf Process Manag. 1991;27(4):379–389.
  • McHayleh W, Sehgal R, Redner RL, et al. Mitoxantrone and etoposide in patients with newly diagnosed acute myeloid leukemia with persistent leukemia after a course of therapy with cytarabine and idarubicin. Leuk Lymphoma. 2009;50(11):1848–1853.
  • Stone RM, Mandrekar SJ, Sanford BL, et al. Midostaurin plus chemotherapy for acute myeloid leukemia with a FLT3 mutation. N Engl J Med. 2017;377(5):454–464.
  • Dohner H, Estey E, Grimwade D, et al. Diagnosis and management of AML in adults: 2017 ELN recommendations from an International Expert Panel. Blood. 2017;129(4):424–447.
  • Cheson BD, Bennett JM, Kopecky KJ, et al. Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia. J Clin Oncol. 2003;21(24):4642–4649.
  • Luskin MR, Lee JW, Fernandez HF, et al. Benefit of high-dose daunorubicin in AML induction extends across cytogenetic and molecular groups. Blood. 2016;127(12):1551–1558.
  • Lindsley RC, Mar BG, Mazzola E, et al. Acute myeloid leukemia ontogeny is defined by distinct somatic mutations. Blood. 2015;125(9):1367–1376.
  • Herold T, Jurinovic V, Batcha AMN, et al. A 29-gene and cytogenetic score for the prediction of resistance to induction treatment in acute myeloid leukemia. Haematologica. 2018;103(3):456–465.
  • Walter RB, Othus M, Burnett AK, et al. Resistance prediction in AML: analysis of 4601 patients from MRC/NCRI, HOVON/SAKK, SWOG and MD Anderson Cancer Center. Leukemia. 2015;29(2):312–320.
  • Krug U, Rollig C, Koschmieder A, et al. Complete remission and early death after intensive chemotherapy in patients aged 60 years or older with acute myeloid leukaemia: a web-based application for prediction of outcomes. Lancet. 2010;376(9757):2000–2008.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.